Liau Gene
EVP Research & Preclinical Dev at STOK
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STOKStoke Therapeutics, Inc.EVP Research & Preclinical Dev
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STOKUnusualMay 22, 2020 2020
Sold 7,500 shares at $30.00 ($225k)
Liau Gene, EVP Research & Preclinical Dev
Sold 35.7% of holdings ($630k position)13,500 shares leftFirst sale on recordFiling
- 2 Form 4 sale STOKUnusualJun 1, 2020 +10 days
Sold 20,000 shares at $26.35 ($527k)
Liau Gene, EVP Research & Preclinical Dev
Sold 59.7% of holdings ($883k position)13,500 shares leftFiling
- 3 Form 4 sale STOKPlan not statedOct 13, 2020 +134 days
Sold 1,649 shares at $40.00 ($66k)
Liau Gene, EVP Research & Preclinical Dev
Sold 10.9% of holdings ($606k position)13,500 shares leftFiling
- 4 Form 4 sale STOKUnusualOct 19, 2020 +6 days
Sold 37,851 shares at $38.15 ($1.4M)
Liau Gene, EVP Research & Preclinical Dev
Sold 73.7% of holdings ($2M position)13,500 shares left5x usual sizeFiling
- 5 Form 4 sale STOKPlan not statedMar 2, 2021 +134 days
Sold 5,344 shares at $62.93 ($336k)
Liau Gene, EVP Research & Preclinical Dev
Sold 20% of holdings ($1.7M position)21,351 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | Mar 4, 2021 | STOK | EVP Research & Preclinical Dev | Form 4 sale | 5,344 | $336k | 20.0% | Plan not stated | SEC |
| Oct 19, 2020 | Oct 20, 2020 | STOK | EVP Research & Preclinical Dev | Form 4 sale | 37,851 | $1.4M | 73.7% | Unusual | SEC |
| Oct 13, 2020 | Oct 13, 2020 | STOK | EVP Research & Preclinical Dev | Form 4 sale | 1,649 | $66k | 10.9% | Plan not stated | SEC |
| Jun 1, 2020 | Jun 3, 2020 | STOK | EVP Research & Preclinical Dev | Form 4 sale | 20,000 | $527k | 59.7% | Unusual | SEC |
| May 22, 2020 | May 26, 2020 | STOK | EVP Research & Preclinical Dev | Form 4 sale | 7,500 | $225k | 35.7% | Unusual | SEC |